Genentech

A biotechnology corporation

Based in CA

🤖

AI Overview

With $1.4M in lobbying spend across 27 quarterly filings, Genentech is a significant lobbying presence.

$1.4M
Total Lobbying Spend
27
Quarterly Filings
1
Lobbying Firms Used
10
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$200K
2019$150K
2020$200K
2021$150K
2022$150K
2023$200K
2024$150K
2025$150K

Lobbying Firms

FORBES-TATE

What They Lobby For

  • Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug reimportation; Issues related to RX drug pricing.
  • Tax related issues.
  • Intellectual property and process patent issues.
  • Issues related to Right to Try.
  • Issues related to Right to Try; Issues related to Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018, S. 2852.
  • Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug reimportation; Issues related to RX drug pricing; Issues related to the International Pricing Index for Medicare Part D.
  • Intellectual property and process patent Issues.
  • Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to RX drug pricing; Issues related to the International Pricing Index for Medicare Part D.
  • Intellectual property and process patent related issues.
  • Issues related to the Capability Maturity Model Integration (CMMI).

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.